Ether

Ether

SCHEMBL6583368

CCOCC.Cl.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL7116616 1.00
Ether SCHEMBL87495 1.00
Ether SCHEMBL17390026 1.00 ALDH1A1 (0.44)
Ether SCHEMBL18045059 1.00
Ether SCHEMBL8322124 1.00 ALDH1A1 (0.44)
Ether SCHEMBL3620984 0.95
Ether SCHEMBL8772802 0.95
Ether SCHEMBL2805781 0.95
Ether SCHEMBL351721 0.95
Ether SCHEMBL5144451 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543891-A1 SOLID STATE FORMS OF DIBUPRENORPHINE ETHYL ETHER AND PROCESS FOR PREPARATION THEREOF Teva Czech Industries s.r.o (CZ) 2025-04-30 EP claimed
CN-222219507-U Catalyst adding structure of diethyl ether dichloride preparation device 连云港海恒生化科技有限公司 2024-12-24 CN claimed
CN-118955896-A Algicide and preparation method and application thereof 廊坊市冀方科技有限公司 2024-11-15 CN claimed
CN-118063296-A Process method for recycling diethyl ether dichloride from ethylene production residual liquid 绍兴东湖高科股份有限公司 2024-05-24 CN claimed
CN-117567357-A Liquid high-temperature-resistant iron ion stabilizer for acidification and preparation method thereof 东营施普瑞石油工程技术有限公司 2024-02-20 CN claimed
WO-2023248161-A1 SOLID STATE FORMS OF DIBUPRENORPHINE ETHYL ETHER AND PROCESS FOR PREPARATION THEREOF TEVA CZECH INDUSTRIES S.R.O (CZ) 2023-12-28 WO claimed
CN-111607943-B Even clothes-horse of illumination 南京善若网络科技有限公司 2023-10-03 CN claimed
CN-116478505-A High-dispersity graphene-based heat dissipation film and preparation method thereof 徐州汇墨新材料科技有限公司 2023-07-25 CN claimed
EP-4100568-A1 PAD-STEAM CATIONIZATION OF TEXTILES Dow Global Technologies LLC (US) 2022-12-14 EP claimed
WO-2021158540-A1 PAD-STEAM CATIONIZATION OF TEXTILES DOW GLOBAL TECHNOLOGIES LLC (US) 2021-08-12 WO claimed
JP-2200812-A None JP disclosed
CN-120607448-A Method for continuously producing benzethonium chloride 潍坊汇韬化工有限公司 2025-09-09 CN disclosed
CN-120136802-A Compound, preparation method thereof and application thereof in preparation of electroplating additive 广东利尔化学有限公司 2025-06-13 CN disclosed
EP-4543891-A1 SOLID STATE FORMS OF DIBUPRENORPHINE ETHYL ETHER AND PROCESS FOR PREPARATION THEREOF Teva Czech Industries s.r.o (CZ) 2025-04-30 EP disclosed
EP-4543891-A1 SOLID STATE FORMS OF DIBUPRENORPHINE ETHYL ETHER AND PROCESS FOR PREPARATION THEREOF Teva Czech Industries s.r.o (CZ) 2025-04-30 EP disclosed
EP-0167355-A2 Thiazolidine derivative and processes for preparing the same Tanabe Seiyaku Co., Ltd. (JP) 1986-01-08 EP disclosed
US-4292035-A COMPLEX OF SMECTITE CLAYS, AMINES, AND ORGANIC SULFONIUM, PHOSPHONIUM, OR QUATERNARY AMMONIUM COMPOUNDS, WITH AN ANIONIC SURFACTANT THE PROCTER & GAMBLE COMPANY (US) 1981-09-29 US disclosed
US-4202958-A WITH AN ETHER AND AN ORGANO-ALUMINUM COMPOUND MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1980-05-13 US disclosed
US-4180584-A ANALGESIC; NARCOTIC ANTAGONIST THE UPJOHN COMPANY (US) 1979-12-25 US disclosed
US-4065573-A ANALGESICS THE UPJOHN COMPANY (US) 1977-12-27 US disclosed